南京公用(000421.SZ):19.9億元成功競得南京江北新區一宗宅地
格隆匯5月28日丨南京公用(000421.SZ)宣佈,公司下屬房地產公司南京中北盛業房地產開發有限公司於2020年5月27日參與南京江北NO.新區2020G03地塊土地使用權競拍,以人民幣19.9億元(樓面地價22975.89元/㎡)、自持租賃住房建面2600㎡成功競得該地塊。
江北NO.新區2020G03地塊(江北新區天浦路以南,新浦路以東地塊),四至為:東至規劃道路,西至新浦路,南至鎮南河路,北至天浦路。總用地面積36088.56㎡,出讓面積36088.56㎡,用地性質為二類居住用地,容積率1.01≤R≤2.4,限高80米,建築密度≤20,綠地率≥35%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.